|
 |
|
Archives
|
|
|
|
|
Dec, 30 |
|
Lupin receives final FDA Approval for Generic TRICOR®Tablets |
|
|
|
Dec, 09 |
|
Lupin receives Tentative Approval for Generic Cymbalta® Delayed-release Capsules |
|
|
|
Dec, 02 |
|
Lupin receives FDA Approval for Generic SOLODYN® Tablets |
|
|
|
Nov, 17 |
|
Lupin Acquires I’rom Pharmaceuticals through its Japanese Subsidiary |
|
|
|
Nov, 09 |
|
Robust Growth, Record Profits-Net Profit Up 24%, Q2 FY 2011-12 |
|
|
|
Oct, 28 |
|
Lupin receives Final FDA Approval for Generic LoSeasonique® Tablets |
|
|
|
Oct, 19 |
|
Lupin receives FDA approval for Generic KEPPRA® Oral Solution 100 mg / mL |
|
|
|
Oct, 11 |
|
Lupin launches Authorized Generic of Femcon® Fe |
|
|
|
Sept, 20 |
|
Lupin Announces U.S. FDA Approval of its First Oral Contraceptive |
|
|
|
Sept, 14 |
|
Lupin Announces Launch of Generic KEPPRA XR® Tablets |
|
|
|
Sept, 02 |
|
Sanofi Aventis & Multicare Ink Strategic Agreement in the Philippines |
|
|
|
Aug, 31 |
|
Lupin Receives Final Approval to Market Generic Ultram® ER |
|
|
|
July, 29 |
|
Eli Lilly India and Lupin announce strategic collaboration to help fight the battle against diabetes |
|
|
|
July, 27 |
|
Consistent Growth, Net Sales up 17% - India and Japan Drive Growth |
|
|
|
July, 25 |
|
Lupin Settles Ongoing Litigation with Medicis over Generic Versions of SOLODYN® |
|
Lupin and Medicis Enter into Joint Development Agreement |
|
|
|
July, 07 |
|
Lupin announces tentative FDA Approval for Pregabalin Capsules |
|
|
|
July, 06 |
|
Lupin Launches Additional Strengths of Generic Lotrel® Capsules |
|
|
|
June, 23 |
|
Lupin in Alliance with Natco to commercialize generic equivalent of Tykerb® Tablets |
|
|
|
June, 22 |
|
Lupin Announces Launch of Generic Levaquin® Tablets for the US Market |
|
|
|
June, 15 |
|
Lupin acquires Worldwide Rights for the Goanna® Brand |
|
|
|
June, 10 |
|
HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer |
|
|
|
June, 01 |
|
Lupin Announces Licensing Arrangement with NeuClone Inks strategic deal with NeuClone for Cell line Technology |
|
|
|
May, 12 |
|
6 Years of Sustained Growth Lupin Net Profit up by 27% in FY 2010-11 |
|
|
|
April, 26 |
|
Lupin announces Patent License Agreement with Abbott |
|
|
|
April, 20 |
|
Lupin announces tentative FDA Approval for Metformin Hydrochloride extended-release tablets 500 mg and 1000 mg |
|
|
|
March, 15 |
|
Lupin to donate Yen 10 mn. for Japan’s earthquake victims |
|
|
Jan, 27 |
|
Lupin Net Profit up by 39 % in Q3, FY 2010-11 Sustained Growth, Strong Profits |
|
|
|
Jan, 14 |
|
Lupin Announces Final FDA Approval for Nabumetone tablets, 500 mg and 750 mg. |
|
|
|
Jan, 05 |
|
LUPIN signs strategic agreement with FARMANGUINHOS, Brazil |
|
|
|
Jan, 03 |
|
Lupin Settles all Ongoing Litigation with Sunovion over Generic of LUNESTA® |
|
|
|
| |
